SB-221284

N/A

Report date: 2025/03/18 15:07:34

NME

Base Information

Drug NameSB-221284

Drug Alias NameSB-221284

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2b (5-HT2b) receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonists

TargetsSerotonin 2b (5-HT2b) receptorSerotonin 2c (5-HT2c) receptor

Therapy Area/IndicationsAnxiety Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSmithkline Beecham

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsAnxiety Disorders

ATC CodeN/A